SNRPN
Overview[edit | edit source]
The SNRPN gene, also known as the small nuclear ribonucleoprotein polypeptide N, is a gene located on chromosome 15 in humans. It is a critical component of the Prader-Willi syndrome (PWS) region and plays a significant role in the regulation of genomic imprinting. The SNRPN gene is involved in the production of small nuclear ribonucleoproteins (snRNPs), which are essential for the splicing of pre-mRNA in the cell nucleus.
Structure[edit | edit source]
The SNRPN gene is located on the long arm of chromosome 15 at position 15q11-q13. It is part of a larger imprinted region that includes several other genes. The gene is expressed from the paternal allele, while the maternal allele is typically silenced due to imprinting. This region is subject to complex epigenetic regulation, which is crucial for normal development and function.
Function[edit | edit source]
SNRPN encodes a protein that is a component of the spliceosomal complex, which is responsible for the removal of introns from pre-mRNA transcripts. This process is vital for the generation of mature mRNA, which is then translated into proteins. The SNRPN protein is part of the U1 snRNP, which is one of the five small nuclear ribonucleoproteins involved in splicing.
Clinical Significance[edit | edit source]
Mutations or deletions in the SNRPN gene, or disruptions in its imprinting, can lead to Prader-Willi syndrome, a genetic disorder characterized by hypotonia, obesity, intellectual disability, and hypogonadism. The loss of function of the paternal allele of SNRPN, along with other genes in the PWS region, is a key factor in the development of this syndrome.
Research and Implications[edit | edit source]
Research into the SNRPN gene and its associated pathways is ongoing, with a focus on understanding the mechanisms of genomic imprinting and its implications in human disease. Studies are also exploring potential therapeutic approaches to correct the imprinting defects associated with Prader-Willi syndrome.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD